These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23071359)

  • 1. Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling.
    Jerby L; Ruppin E
    Clin Cancer Res; 2012 Oct; 18(20):5572-84. PubMed ID: 23071359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From cancer metabolism to new biomarkers and drug targets.
    Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L
    Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic network modeling and simulation for drug targeting and discovery.
    Kim HU; Sohn SB; Lee SY
    Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting selective drug targets in cancer through metabolic networks.
    Folger O; Jerby L; Frezza C; Gottlieb E; Ruppin E; Shlomi T
    Mol Syst Biol; 2011 Jun; 7():501. PubMed ID: 21694718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality data.
    Durot M; Le Fèvre F; de Berardinis V; Kreimeyer A; Vallenet D; Combe C; Smidtas S; Salanoubat M; Weissenbach J; Schachter V
    BMC Syst Biol; 2008 Oct; 2():85. PubMed ID: 18840283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General approach to identifying potential targets for cancer imaging by integrated bioinformatics analysis of publicly available genomic profiles.
    Yang Y; Adelstein SJ; Kassis AI
    Mol Imaging; 2011 Apr; 10(2):123-34. PubMed ID: 21439257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.
    Natarajan TG; Ganesan N; Fitzgerald KT
    Cancer Biomark; 2010; 9(1-6):65-99. PubMed ID: 22112470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer.
    Jerby L; Wolf L; Denkert C; Stein GY; Hilvo M; Oresic M; Geiger T; Ruppin E
    Cancer Res; 2012 Nov; 72(22):5712-20. PubMed ID: 22986741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as molecular biomarkers of cancer.
    Fabbri M
    Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor vascular biomarkers: new opportunities for cancer diagnostics.
    Li C; Sasaroli D; Chen X; Hu J; Sandaltzopoulos R; Omidi Y; Coukos G
    Cancer Biomark; 2010-2011; 8(4-5):253-71. PubMed ID: 22045357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular medicine and the development of cancer chemopreventive agents.
    Izzotti A
    Ann N Y Acad Sci; 2012 Jul; 1259():26-32. PubMed ID: 22758633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstruction of genome-scale human metabolic models using omics data.
    Ryu JY; Kim HU; Lee SY
    Integr Biol (Camb); 2015 Aug; 7(8):859-68. PubMed ID: 25730289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment.
    Masoudi-Nejad A; Asgari Y
    Semin Cancer Biol; 2015 Feb; 30():21-9. PubMed ID: 24495661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR evaluation of response to targeted treatment in cancer cells.
    Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
    NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression 'signature' limitations and genome architecture-based perspectives for robust cancer biomarkers.
    Katsios CS; Papaloukas C; Roukos DH; Baltogiannis G
    Biomark Med; 2013 Feb; 7(1):79-82. PubMed ID: 23387487
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome scale metabolic modeling of cancer.
    Nilsson A; Nielsen J
    Metab Eng; 2017 Sep; 43(Pt B):103-112. PubMed ID: 27825806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.